Introduction {#s1}
============

Sleep is essential for health, and people with diabetes are frequently beset with sleep disturbances. According to the American Psychiatric Association, sleep disorder involves problems with the quality, timing, and amount of sleep, which cause problems with functioning and distress during the daytime. However, the concept of sleep disorder in people with diabetes has not been clearly defined and investigated. Sleep disorder is more prevalent in patients with diabetes than people without diabetes ([@B1]). Sleep disorder increases the risk of insomnia, hyperglycemia, cardiovascular disease, and cancer ([@B2], [@B3]). In the treatment of diabetes, less attention had been paid to sleep disorder than diet restriction and exercise.

Sleep is controlled by circadian and homeostatic mechanisms ([@B4]). The photoentrainment in circadian rhythm is initiated by stimulating intrinsically photosensitive retinal ganglion cells (ipRGCs) with strong blue light ([@B5]). The blue light stimulus is transmitted via the suprachiasmatic nucleus to the pineal gland, which secretes melatonin and controls sleep ([@B6]). Because ipRGCs receive signals from photoreceptors via the synapse with rod bipolar cells and amacrine cells ([@B7]), the altered circadian rhythm might be caused by impaired ipRGCs, photoreceptors, or/and a synapse between them. Although the temporal structures of daily life influence sleep, their impacts on the macular neuroretinal layer thickness had never been reported. Diabetic retinopathy and neuropathy influence the thickness of the macular neuroretinal layers ([@B8], [@B9]) and sleep disorder ([@B10], [@B11]); however, these have not been investigated in detail. Recently, Dumpala et al. ([@B12]) reported that the thinning and dysfunction of the outer retina in the small number of patients with type 2 diabetes may contribute to poor sleep behavior. However, they did not find a significant direct association between the thicknesses at the individual grids defined by the Early Treatment Diabetic Retinopathy Study (ETDRS) of outer retinal layers and the components of sleep disorder.

In the current paper, we assessed the impact of the thinning at individual ETDRS grids of all macular neuroretinal layers, clinical factors, and the inadequate light exposure on each component of sleep disorder in type 2 diabetic patients without clinical evidence of diabetic retinopathy and neuropathy.

Subjects and Methods {#s2}
====================

Subjects
--------

One hundred forty-one Japanese patients with type 2 diabetes and 54 sex- and age-matched healthy control subjects were investigated. The exclusion criteria were as follows: older than 55 years, shift worker, restless legs syndrome, sleep apnea, crystalline lens opacity, any grade of diabetic retinopathy, color blindness, best-corrected visual acuity \< 1.0, signs of glaucomatous optic discs, and history of ophthalmic surgery.

Clinical and Laboratory Data
----------------------------

BMI, blood pressure, HbA1c levels, serum creatinine, lipid levels (LDL-cholesterol, HDL-cholesterol, and triglycerides), and urinary creatinine and albumin were measured in all subjects.

Evaluation of Sleep Disorder and Temporal Structures of Daily Life
------------------------------------------------------------------

The Pittsburgh Sleep Quality Index Japanese Version (PSQI-J) was used to assess the subjective sleep disorder over the past month. PSQI-J contains 18-item self-report questionnaires: these items produce seven components (sleep quality, sleep-onset latency, sleep duration, sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction) that range from 0 (no difficulty) to 3 (severe difficulty). The sum of these component scores yields a global sleep quality (global score). The global score \> 5.5 was considered to have sleep disorder ([@B13], [@B14]). The presence of pain during sleep was recorded by PSQI-J. The chronotype and social jetlag were evaluated by Munich Chronotype Questionnaire-Japanese Version based on typical behavior on workdays and work-free days over the past 4 weeks. The chronotype was assessed as midsleep on free days sleep corrected. The temporal structures of daily life were assessed separately for workdays and free days. As the period of various light source exposures, the daily duration of television watching, personal computer operation, mobile phone use, and spent outside under the sunlight was estimated using a personal life behavior table ([@B15]).

Assessment of Neuropathy
------------------------

All subjects underwent detailed clinical and neurological examinations. Neurological deficits were assessed using the modified neuropathy disability score ([@B16]), which evaluates vibration perception, pinprick, temperature perception, and ankle reflexes. The classification for evaluation of neuropathy was based on the Toronto neuropathy consensus ([@B17]), which considers a confirmed diabetic peripheral neuropathy as a combination of the presence of abnormal nerve conduction velocity and a symptom, or a sign. As a result, patients with neuropathy disability score \> 2 and sensory nerve conduction velocity of sural nerve \< 42 m/s were labeled with neuropathy, which has been excluded from this study. Electrophysiology and nerve conduction velocity studies were performed using an electromyography instrument (Neuropak-S1, NIHON KOHDEN, Tokyo, Japan). The motor nerve conduction velocity of the median nerve, the sensory nerve conduction velocity of the sural nerve, and their action potential amplitudes were determined. Skin temperature was maintained above 32°C. The vibration perception threshold was measured at the left medial malleolus using a biothesiometer (Biomedical Instruments, Newbury, OH, USA). Warm and cold perception thresholds at the dorsum of the foot were determined using a thermal stimulator (Intercross-200, Intercross Co., Tokyo, Japan). The coefficient of variation of R-R intervals (CVR-R) was calculated from the R-R intervals of 200 electrocardiogram samples.

Corneal Confocal Microscopy
---------------------------

All subjects were examined using a Heidelberg Retina Tomograph III *in vivo* corneal confocal microscope with Rostock Corneal Module (Heidelberg Engineering, Heidelberg, Germany) ([@B18]). Six high-quality images per subject from Bowman\'s layer were captured and analyzed to quantify the following corneal nerve fiber morphological parameters: (1) corneal nerve fiber density: total number of major nerve fibers/mm^2^ of corneal tissue; (2) corneal nerve fiber length: total length of all nerve fibers (mm/mm^2^); (3) corneal nerve branch density: number of branches emanating from all major nerve trunks/mm^2^; (4) beading frequency/0.1 mm); and (5) bead size (μm^2^) ([@B19]). Except for bead size, all measurements were performed using ImageJ (Texelcraft, Tokyo, Japan).

Swept-Source Optical Coherence Tomography (SS-OCT) and Automated Segmentation
-----------------------------------------------------------------------------

The OCT images of the right eye were obtained with SS-OCT (DRI OCT Triton, Topcon Corp., Tokyo, Japan) for all subjects. The only high-quality images with an image quality factor of Topcon ≥ 60% and without artifact were employed. For the segmentation of the all macular neuroretinal layers, OCT-Explorer ([@B20]) was implemented to automatically identify nine retinal interfaces and assess the following layer thickness: (1) retinal nerve fiber (RNFL), (2) ganglion cell (GCL), (3) inner plexiform (IPL), (4) inner nuclear (INL), (5) outer plexiform (OPL), (6) outer nuclear (ONL), (7) junction of inner and outer segment (OS) of photoreceptor (IS/OS), (8) OS, (9) OS/retinal pigment epithelium (RPE) complex (OPR), and (10) RPE (RPE + Bruch\'s membrane). The thickness of the central, pericentral, and peripheral rings with diameters of 1, 3, and 6 mm defined by ETDRS was measured. The thickness of the following nine grids of the macular neuroretinal layers and RPE was estimated: central fovea, inner and outer nasal, superior, temporal, and inferior.

Ophthalmic Examinations
-----------------------

The visual acuity was measured using the international type visual acuity chart (Tsutsumi, Tokyo, Japan). The color blindness was diagnosed by the Ishihara color test. The bilateral fundus images were captured (the field of assessment: 45°) for all subjects at the time of SS-OCT using DRI OCT Triton (Topcon Corp., Tokyo, Japan) without pupil dilatation.

Statistical Analysis
--------------------

All statistical analyses were performed using SPSS ver. 19 (SPSS, Chicago, IL, USA), and *p* \< 0.05 was considered statistically significant. A *post-hoc* analysis of sample power using Gpower 3.1 (<http://gpower.software.informer.com/3.1/>) was conducted using a Mann--Whitney test (significance of 0.05) for PSQI-J scores and OCT measures. The present study population provided statistical power ranging from 0.71 to 0.99.

All values are presented as the mean ± standard error of the mean. All data sets were tested for normality using the Shapiro--Wilk test. The differences between controls and type 2 diabetic patients without diabetic neuropathy or between patients with or without statin use were assessed using *t*-test and Mann-Whitney test for normally and non-normally distributed continuous variables and χ^2^ test for categorical variables. Correlations between the PSQI-J scores and clinical factors were assessed with multiple regression analysis. The associations among the PSQI-J scores, neurophysiological tests, corneal nerve fiber measures, thickness at grids of macular neuroretinal layers, clinical factors, and temporal structures of daily life in patients with type 2 diabetes were assessed using Spearman\'s rank correlation coefficient analysis.

Results {#s3}
=======

In order to exclude the potential impact of diabetic neuropathy on sleep disorder and the thickness of the macular neuroretinal layers, 17 patients with confirmed diabetic neuropathy defined by Toronto criteria were excluded, and further analyses were performed using 124 patients without diabetic neuropathy. Hence, the current paper focuses only on type 2 diabetic patients without clinical evidences of diabetic neuropathy and retinopathy.

Clinical Characteristics
------------------------

Sex and age were matched between controls and diabetic patients without diabetic neuropathy. BMI, blood pressure, HbA1c levels, LDL-cholesterol, triglycerides, and urinary albumin-to-creatinine ratio in patients with type 2 diabetes were higher, and HDL-cholesterol was lower than those in control subjects ([Table 1](#T1){ref-type="table"}). LDL-cholesterol in diabetic patients with or without statin use was not significantly different (*p* = 0.171).

###### 

Clinical characteristics, neurophysiological tests, and corneal nerve fiber measures in control subjects and patients with type 2 diabetes without diabetic neuropathy.

                                                               **Control subjects**   **Patients with type 2 diabetes without diabetic neuropathy**   ***P*-value**
  ------------------------------------------------------------ ---------------------- --------------------------------------------------------------- ---------------
  **CLINICAL DATA**                                                                                                                                   
  Number (Male/Female, M %)                                    54 (34/20, 63.0)       124 (78/46, 62.9)                                               NS
  Age (years)                                                  48.6 ± 1.2             48.6 ± 0.7                                                      NS
  Duration of diabetes (years)                                 −                      8.7 ± 0.7                                                       
  Body mass index (BMI, kg/m^2^)                               23.3 ± 0.4             27.6 ± 0.5                                                      \<0.001
  Systolic blood pressure (SBP, mmHg)                          127 ± 1.7              132 ± 1.5                                                       0.049
  Diastolic blood pressure (DBP, mmHg)                         75.6 ± 1.1             79.7 ± 0.9                                                      0.018
  No. treated with angiotensin receptor blocker (%)            18.5                   27.4                                                            NS
  HbA1c (%)                                                    5.6 ± 0.05             8.3 ± 0.17                                                      \<0.001
  Low density lipoprotein (LDL) cholesterol (mmol/L)           3.02 ± 0.09            3.51 ± 0.08                                                     \<0.001
  No. treated with statins (%)                                 14.8                   11.2                                                            NS
  High density lipoprotein (HDL) cholesterol (mmol/L)          1.76 ± 0.07            1.43 ± 0.04                                                     \<0.001
  Triglycerides (mmol/L)                                       1.49 ± 0.19            2.53 ± 0.23                                                     \<0.001
  Urinary albumin to creatinine ratio (ACR, mg/g creatinine)   9.45 ± 1.4             63.9 ± 19.5                                                     0.001
  Estimated glomerular filtration rate (eGFR, ml/min)          84.3 ± 2.5             87.0 ± 1.9                                                      NS
  **NEUROPHYSIOLOGICAL TESTS**                                                                                                                        
  Neuropathy disability score                                  0.43 ± 0.07            3.84 ± 0.24                                                     \<0.001
  Motor nerve conduction velocity of median nerve (m/s)        57.9 ± 0.65            53.8 ± 0.38                                                     \<0.001
  Amplitude of median nerve (mV)                               8.72 ± 0.41            7.51 ± 0.30                                                     0.004
  Sensory nerve conduction velocity of sural nerve (m/s)       48.5 ± 0.62            47.7 ± 0.42                                                     NS
  Amplitude of sural nerve (μV)                                15.4 ± 0.94            12.4 ± 0.55                                                     0.004
  Vibration perception threshold (μ/120cycles/s)               1.94 ± 0.16            2.94 ± 0.24                                                     0.008
  Coefficient of variation of R-R interval (%)                 4.05 ± 0.19            3.60 ± 0.13                                                     0.027
  Warm perception threshold (W/m^2^)                           −468 ± 10.6            −671 ± 74.0                                                     \<0.001
  Cold perception threshold (W/m^2^)                           454 ± 12.1             496 ± 12.7                                                      NS
  **CORNEAL NERVE FIBER MEASURES**                                                                                                                    
  Corneal nerve fiber density (no/mm^2^)                       30.9 ± 0.78            22.8 ± 0.42                                                     \<0.001
  Corneal nerve fiber length (mm/mm^2^)                        15.0 ± 0.28            12.1 ± 0.19                                                     \<0.001
  Corneal nerve branch density (no/mm^2^)                      13.5 ± 0.65            11.3 ± 0.31                                                     0.012
  Beading frequency (no/0.1mm)                                 23.5 ± 0.26            20.3 ± 0.16                                                     \<0.001
  Bead size (μm^2^)                                            8.18 ± 0.075           10.8 ± 0.092                                                    \<0.001

*Data are the mean ± standard error of the mean in control subjects and patients with type 2 diabetes without diabetic neuropathy*.

*P-values are between control subjects and type 2 diabetic patients without neuropathy*.

Subjective Sleep Disorder and Temporal Structures of Daily Life
---------------------------------------------------------------

The global score, prevalence of sleep disorder, and four individual scores of sleep disorder in patients were significantly higher than controls ([Table 2](#T2){ref-type="table"}). In patients without statin use, the global score (*p* = 0.016) and sleep duration score (*p* = 0.048) were higher than patients with statin use. Among 124 patients without diabetic neuropathy, 11 (8.9%) patients complained of some pain during sleep. The prevalence of sleep disorder in patients with pain was higher than patients without pain (*p* = 0.043). None of individual sleep disorder scores was different between patients with or without pain (*p* = 0.082--0.380).

###### 

Subjective sleep disorder estimated by Pittsburgh Sleep Quality Index Japanese Version and temporal structures of daily life estimated by Munich Chronotype Questionnaire Japanese Version in control subjects and patients with type 2 diabetes without diabetic neuropathy.

                                                                           **Control subjects**   **Patients with type 2 diabetes without diabetic neuropathy**   ***P*-value**
  ------------------------------------------------------------- ---------- ---------------------- --------------------------------------------------------------- ---------------
  **SCORES OF SUBJECTIVE SLEEP DISORDER ESTIMATED BY PSQI-J**                                                                                                     
  Global score                                                             3.26 ± 0.22            4.80 ± 0.24                                                     \<0.001
  Prevalence of sleep disorder (global score: \> 5.5%)                     3.7                    28.2                                                            \<0.001
  Sleep quality                                                            0.89 ± 0.09            1.20 ± 0.07                                                     0.007
  Sleep-onset latency                                                      0.30 ± 0.07            0.68 ± 0.08                                                     0.004
  Sleep duration                                                           1.11 ± 0.11            1.25 ± 0.08                                                     NS
  Sleep efficiency                                                         0.06 ± 0.031           0.19 ± 0.053                                                    NS
  Sleep disturbance                                                        0.67 ± 0.070           0.80 ± 0.049                                                    NS
  Use of sleep medications                                                 0                      0.17 ± 0.058                                                    0.043
  Daytime dysfunction                                                      0.19 ± 0.053           0.52 ± 0.068                                                    0.004
  **TEMPORAL STRUCTURES OF DAILY LIFE ESTIMATED BY MCQ-J**                                                                                                        
  Television watching time (min/day)                            Work day   91.3 ± 7.2             150 ± 11.3                                                      0.003
                                                                Free day   127 ± 10.9             216 ± 15.4                                                      0.001
  Personal computer operating time (min/day)                    Work day   124 ± 19.3             124 ± 16.1                                                      NS
                                                                Free day   25.9 ± 6.7             26.7 ± 5.5                                                      NS
  Mobile phone using time (min/day)                             Work day   62.0 ± 10.3            69.5 ± 6.3                                                      NS
                                                                Free day   60.6 ± 9.9             76.0 ± 7.0                                                      NS
  Sunlight exposure time (min/day) at outdoor                   Work day   96.0 ± 16.0            86.7 ± 12.3                                                     NS
                                                                Free day   135 ± 14.3             85.9 ± 10.6                                                     \<0.001
  Chronotype (local time)                                                  02:58±(19min)          03:10±(15min)                                                   NS
  Social jet-lag (hr)                                                      0.98 ± 0.28            0.73 ± 0.08                                                     NS

*Data are the mean ± standard error of the mean in control subjects and patients with type 2 diabetes without diabetic neuropathy*.

*P-values are between control subjects and type 2 diabetic patients without diabetic neuropathy*.

*MCQ-J, Munich Chronotype Questionnaire-Japanese Version; PSQI-J, Pittsburgh Sleep Quality Index Japanese Version*.

Television watching time on work and the free day was longer, and sunlight exposure time on free day was shorter in patients without diabetic neuropathy than controls ([Table 2](#T2){ref-type="table"}).

Neurophysiological Tests and Corneal Nerve Fiber Measures
---------------------------------------------------------

Neuropathy disability score was higher in patients with type 2 diabetes than controls. All neurophysiological tests except for the sensory nerve conduction velocity of sural nerve and cold perception threshold in patients without diabetic neuropathy were impaired compared with controls. All corneal nerve fiber morphological measures in patients without diabetic neuropathy were altered compared with controls ([Table 1](#T1){ref-type="table"}).

Alterations in Macular Neuroretinal Layers and RPE
--------------------------------------------------

The representative OCT image of a control subject showing individual macular neuroretinal layers is presented in [Figure 1](#F1){ref-type="fig"}. At the inner retinal layers, the thickness at two grids of GCL and five grids of IPL in patients with type 2 diabetes was thinner than that in control subjects. At the outer retinal layers, the thickness at four ONL grids, seven IS/OS grids, four OS grids, and six OPR grids in patients with type 2 diabetes was thinner than that in control subjects. The thickness at an RPE grid in patients was thinner than that in control subjects ([Table 3](#T3){ref-type="table"}).

![Representative optical coherence tomography (OCT) image of macular neuroretinal layers visualized by swept-source OCT and OCT-Explorer in a healthy control subject. ELM, external limiting membrane; GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; IS/OS, junction of inner segment/outer segment of photoreceptor; ONL, outer nuclear layer; OPL, outer plexiform layer; OPR, outer segment of photoreceptor/retinal pigment epithelium complex; OS, outer segment; RNFL, retinal nerve fiber layer; RPE, retinal pigment epithelium.](fendo-11-00069-g0001){#F1}

###### 

Thickness at ETDRS grids of macular neuroretinal layers and retinal pigment epithelium in control subjects and patients with type 2 diabetes without diabetic neuropathy.

                                                                                                                     **Control subjects**   **Patients with type 2 diabetes without diabetic neuropathy**   ***P*-value**
  ------------------------------------------------------------------------------------------------- ---------------- ---------------------- --------------------------------------------------------------- ---------------
  **Thickness at ETDRS grids of macular neuroretinal layers and retinal pigment epithelium (μm)**                                                                                                           
  Ganglion cell layer                                                                               Inner superior   49.3 ± 0.97            45.8 ± 0.75                                                     0.010
                                                                                                    Inner inferior   45.4 ± 0.98            42.7 ± 0.66                                                     0.036
  Inner plexiform layer                                                                             Central fovea    24.2 ± 0.65            22.1 ± 0.32                                                     0.009
                                                                                                    Inner nasal      41.9 ± 0.77            38.7 ± 0.37                                                     0.022
                                                                                                    Inner superior   37.8 ± 0.65            35.5 ± 0.39                                                     0.003
                                                                                                    Outer superior   40.6 ± 0.47            38.5 ± 0.34                                                     0.039
                                                                                                    Outer inferior   40.7 ± 0.49            39.3 ± 0.33                                                     0.012
  Outer nuclear layer                                                                               Inner superior   89.9 ± 1.7             85.1 ± 1.0                                                      0.008
                                                                                                    Inner temporal   93.5 ± 1.3             89.5 ± 0.97                                                     0.010
                                                                                                    Outer superior   79.7 ± 1.0             76.8 ± 0.66                                                     0.031
                                                                                                    Outer temporal   73.9 ± 0.73            70.7 ± 0.61                                                     0.002
  IS/OS                                                                                             Central fovea    15.6 ± 0.11            15.0 ± 0.11                                                     \<0.001
                                                                                                    Inner nasal      13.6 ± 0.12            12.9 ± 0.10                                                     \<0.001
                                                                                                    Inner superior   13.9 ± 0.10            13.3 ± 0.09                                                     \<0.001
                                                                                                    Inner temporal   13.8 ± 0.10            13.1 ± 0.10                                                     \<0.001
                                                                                                    Outer nasal      12.1 ± 0.17            11.3 ± 0.15                                                     0.001
                                                                                                    Outer superior   13.1 ± 0.10            12.5 ± 0.11                                                     \<0.001
                                                                                                    Outer inferior   13.0 ± 0.10            12.5 ± 0.11                                                     0.002
  Outer segment                                                                                     Inner nasal      14.2 ± 0.08            13.9 ± 0.09                                                     0.040
                                                                                                    Inner temporal   14.3 ± 0.08            14.0 ± 0.09                                                     0.049
                                                                                                    Outer nasal      14.0 ± 0.08            13.5 ± 0.13                                                     0.002
                                                                                                    Outer temporal   14.8 ± 0.15            14.2 ± 0.10                                                     0.001
  OPR                                                                                               Central fovea    15.5 ± 0.08            14.9 ± 0.14                                                     0.002
                                                                                                    Inner nasal      14.6 ± 0.07            14.2 ± 0.13                                                     0.049
                                                                                                    Inner temporal   14.7 ± 0.06            14.2 ± 0.13                                                     0.004
                                                                                                    Inner inferior   14.8 ± 0.07            14.3 ± 0.13                                                     0.022
                                                                                                    Outer temporal   14.1 ± 0.09            13.7 ± 0.13                                                     0.019
                                                                                                    Outer inferior   14.4 ± 0.09            13.9 ± 0.13                                                     0.043
  Retinal pigment epithelium                                                                        Outer superior   18.3 ± 0.10            17.7 ± 0.13                                                     0.022

*Data are the mean ± standard error of the mean in control subjects and patients with type 2 diabetes without diabetic neuropathy*.

*P-values are between control subjects and type 2 diabetic patients without diabetic neuropathy*.

*ETDRS, Early Treatment Diabetic Retinopathy Study; IS/OS, junction of inner and outer segment of photoreceptor;OPR, outer segment of photoreceptor/retinal pigment epithelium complex*.

Associations Among PSQI-J Scores, Clinical Characteristics, Thickness of Macular Neuroretinal Layers, Neurophysiological Tests, Corneal Nerve Fiber Measures, and Temporal Structures of Daily Life in Patients With Type 2 Diabetes Without Diabetic Neuropathy
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HbA1c levels were positively associated with the global score (β = 0.187, *p* = 0.037) and the scores of use of sleep medications (β = 0.196, *p* = 0.029) and daytime dysfunction (β = 0.312, *p* \< 0.001). Serum LDL-cholesterol levels were positively associated with the global score (β = 0.177, *p* = 0.049) and the scores of sleep quality (β = 0.250, *p* = 0.005) and daytime dysfunction (β = 0.315, *p* \< 0.001). Unexpectedly, age and BMI were not related to the scores of sleep disorder.

The global score was negatively associated with an ONL grid thickness. The sleep quality score was negatively related to the thickness at a grid of IS/OS, two grids of OS, eight grids of OPR, and median nerve amplitude. The sleep efficiency score was negatively related to a thickness at two IPL grids, a grid of ONL and IS/OS, and five grids of OPR and CVR-R. The sleep disturbance score was negatively associated with the thickness at an IPL grid and three OPR grids. The use of sleep medication score was negatively associated with the thickness at a grid of IPL and INL, four ONL grids, and beading frequency. The daytime dysfunction score was negatively linked to the thickness at seven ONL grids and positively linked to bead size ([Table 4](#T4){ref-type="table"}).

###### 

Linear regression between components of Pittsburgh Sleep Quality Index Japanese Version and the thickness at grids defined by Early Treatment Diabetic Retinopathy Study of macular neuroretinal layers, neurophysiological tests or corneal nerve fiber measures in patients with type 2 diabetes without diabetic neuropathy.

                                **Scores of Pittsburgh Sleep Quality Index Japanese Version**                                                                                                                                              
  ----------------------------- --------------------------------------------------------------- ----------- -------- ----------- -------- ------- -------- ------- -------- ----------- -------- ----------- -------- ----------- -------- -------------
  **THICKNESS OF MNL**                                                                                                                                                                                                                     
  **Inner plexiform**                                                                                                                                                                                                                      
  Inner superior                −0.074                                                          0.416       −0.137   0.129       0.053    0.555   0.055    0.544   −0.178   **0.048**   −0.180   **0.046**   −0.107   0.236       −0.109   0.230
  Inner temporal                −0.091                                                          0.313       −0.119   0.188       0.066    0.469   −0.075   0.411   −0.226   **0.012**   −0.125   0.167       −0.029   0.747       −0.055   0.547
  Outer nasal                   −0.058                                                          0.525       −0.116   0.201       −0.041   0.653   0.116    0.199   0.049    0.588       0.055    0.546       −0.212   **0.018**   −0.092   0.310
  **Inner nuclear**                                                                                                                                                                                                                        
  Outer temporal                −0.006                                                          0.950       0.067    0.462       0.007    0.937   0.132    0.143   0.035    0.697       −0.032   0.722       −0.194   **0.031**   0.031    0.729
  **Outer nuclear**                                                                                                                                                                                                                        
  Central fovea                 −0.082                                                          0.362       −0.072   0.430       −0.012   0.893   0.132    0.143   −0.069   0.445       0.005    0.956       −0.296   **0.001**   −0.193   **0.032**
  Inner nasal                   −0.169                                                          0.060       −0.037   0.684       −0.041   0.653   −0.057   0.528   −0.089   0.328       0.021    0.816       −0.192   **0.033**   −0.297   **0.001**
  Inner superior                −0.156                                                          0.083       −0.115   0.201       −0.085   0.345   0.030    0.742   0.000    1.000       0.024    0.795       −0.281   **0.002**   −0.268   **0.003**
  Inner temporal                −0.189                                                          **0.037**   −0.101   0.265       −0.118   0.192   0.002    0.978   −0.006   0.948       −0.063   0.486       −0.148   0.101       −0.086   0.341
  Inner inferior                −0.098                                                          0.277       −0.064   0.482       0.012    0.894   0.049    0.590   −0.184   **0.044**   0.013    0.888       −0.140   0.120       −0.207   **0.021**
  Outer nasal                   −0.126                                                          0.162       −0.008   0.934       −0.055   0.541   −0.061   0.501   0.016    0.857       −0.002   0.980       −0.147   0.102       −0.351   **\<0.001**
  Outer superior                −0.141                                                          0.120       −0.041   0.649       −0.136   0.132   −0.017   0.853   −0.037   0.683       0.017    0.847       −0.259   **0.004**   −0.192   **0.033**
  Outer inferior                −0.109                                                          0.229       −0.050   0.581       −0.036   0.691   0.026    0.778   −0.147   0.104       −0.024   0.793       −0.165   0.068       −0.284   **0.001**
  **IS/OS**                                                                                                                                                                                                                                
  Outer nasal                   −0.083                                                          0.357       −0.243   **0.006**   −0.036   0.694   −0.106   0.242   −0.193   **0.032**   0.028    0.755       0.124    0.170       −0.050   0.579
  **Outer segment**                                                                                                                                                                                                                        
  Outer nasal                   −0.075                                                          0.406       −0.182   **0.043**   −0.007   0.942   −0.058   0.524   −0.111   0.218       0.082    0.363       0.003    0.977       −0.035   0.700
  Outer inferior                −0.049                                                          0.587       −0.195   **0.030**   0.012    0.894   −0.042   0.639   −0.077   0.397       −0.008   0.926       0.050    0.583       −0.022   0.807
  **OPR**                                                                                                                                                                                                                                  
  Inner nasal                   −0.044                                                          0.630       −0.178   **0.049**   0.049    0.592   −0.044   0.630   −0.207   **0.021**   0.028    0.759       0.000    0.997       −0.040   0.659
  Inner superior                −0.037                                                          0.684       −0.183   **0.042**   0.031    0.729   0.009    0.918   −0.129   0.152       −0.126   0.162       0.046    0.615       −0.021   0.815
  Inner temporal                −0.097                                                          0.284       −0.261   **0.003**   0.069    0.446   0.074    0.412   −0.213   **0.018**   −0.186   **0.039**   −0.031   0.733       −0.102   0.260
  Inner inferior                −0.106                                                          0.243       −0.277   **0.002**   0.059    0.516   0.052    0.567   −0.124   0.170       −0.207   **0.021**   −0.047   0.607       −0.147   0.103
  Outer nasal                   −0.130                                                          0.152       −0.193   **0.034**   0.038    0.677   0.017    0.815   −0.155   0.086       0.028    0.755       −0.112   0.214       −0.163   0.070
  Outer superior                −0.129                                                          0.154       −0.209   **0.020**   0.050    0.580   0.062    0.495   −0.235   **0.009**   −0.138   0.125       −0.087   0.338       −0.064   0.477
  Outer temporal                −0.105                                                          0.244       −0.209   **0.020**   0.009    0.917   0.119    0.190   −0.220   **0.014**   −0.179   **0.048**   −0.045   0.623       −0.066   0.470
  Outer inferior                −0.116                                                          0.200       −0.184   **0.041**   −0.025   0.779   0.085    0.348   −0.202   **0.024**   −0.065   0.471       −0.069   0.448       −0.149   0.098
  **Neurophysiological test**                                                                                                                                                                                                              
  Amp of median N               0.029                                                           0.753       −0.200   **0.026**   −0.110   0.222   0.053    0.559   −0.103   0.256       −0.054   0.548       0.130    0.152       −0.042   0.646
  CVR-R                         −0.008                                                          0.925       −0.119   0.189       −0.008   0.929   0.009    0.920   −0.227   **0.011**   −0.107   0.236       0.053    0.560       −0.016   0.863
  **CNF measures**                                                                                                                                                                                                                         
  BF                            −0.139                                                          0.123       −0.081   0.374       −0.122   0.177   0.012    0.892   0.146    0.106       −0.033   0.716       −0.185   **0.040**   −0.131   0.148
  Bead size                     0.166                                                           0.066       0.090    0.320       −0.001   0.990   −0.028   0.762   −0.058   0.525       0.154    0.087       0.162    0.073       0.248    **0.006**

*Bold p-value reveals p \< 0.05*.

*Amp, amplitude; BF, beading frequency; CNF; corneal nerve fiber; CVR-R, coefficient of variation of R-R interval; IS/OS, junction of inner and outer segment of photoreceptor; MNL, macular neuroretinal layer; N, nerve; OPR, outer segment of photoreceptor/retinal pigment epithelium complex*.

Age was negatively related to the thickness at a grid of RNFL, GCL, and IPL, while it was positively related to the thickness at one to three grids of IS/OS, OS, and RPE. BMI was positively related to the thickness at one to three grids of GCL, INL, and OPL. HbA1c levels were positively related to the thickness at one to three grids of RNFL, GCL, INL, and RPE, and negatively related to the thickness at one to seven grids of IS/OS, OS, and OPR. The LDL-cholesterol levels were positively related to the thickness at one to three grids of three inner retinal layers and negatively related to the thickness at one to three grids of four outer retinal layers. HDL-cholesterol levels were positively associated with the thickness at one to five grids of IPL, ONL, and IS/OS. The triglycerides were negatively related to the thickness at one to four grids of three outer retinal layers, while positively to the thickness at four RPE grids ([Table 5](#T5){ref-type="table"}).

###### 

Linear regression between clinical factors and thickness at grids defined by Early Treatment Diabetic Retinopathy Study of macular neuroretinal layers and RPE in patients with type 2 diabetes without diabetic neuropathy.

  **Grids of macular neuroretinal layers and RPE**   **Clinical factors in patients with type 2 diabetes without diabetic neuropathy**                                                                                                              
  -------------------------------------------------- ----------------------------------------------------------------------------------- ----------- -------- ----------- -------- ------------- -------- ----------- -------- ----------- -------- -----------
  **RNF**                                                                                                                                                                                                                                           
  Central fovea                                      −0.244                                                                              **0.006**   0.081    0.373       0.141    0.118         −0.062   0.494       −0.107   0.269       0.035    0.697
  Inner temporal                                     0.100                                                                               0.270       −0.037   0.687       0.155    0.086         0.202    **0.024**   −0.102   0.259       0.114    0.209
  Inner inferior                                     0.004                                                                               0.967       0.115    0.202       0.255    **0.004**     0.065    0.470       −0.170   0.059       0.128    0.157
  **Ganglion cell**                                                                                                                                                                                                                                 
  Central fovea                                      −0.181                                                                              **0.044**   0.048    0.595       0.107    0.239         0.045    0.618       −0.083   0.357       0.065    0.473
  Inner temporal                                     0.085                                                                               0.351       0.068    0.452       0.083    0.357         0.294    **0.001**   0.016    0.862       0.056    0.539
  Inner inferior                                     −0.005                                                                              0.956       0.020    0.830       0.184    **0.041**     0.171    0.058       −0.076   0.401       0.058    0.522
  Outer temporal                                     0.003                                                                               0.978       0.185    **0.040**   0.026    0.776         0.157    0.081       −0.011   0.900       0.040    0.656
  **Inner plexiform**                                                                                                                                                                                                                               
  Inner nasal                                        0.031                                                                               0.730       −0.091   0.313       −0.084   0.354         −0.034   0.705       0.178    **0.048**   −0.176   0.050
  Inner temporal                                     −0.180                                                                              **0.046**   −0.015   0.871       0.124    0.172         −0.057   0.530       −0.075   0.409       −0.069   0.449
  **Inner nuclear**                                                                                                                                                                                                                                 
  Inner nasal                                        0.063                                                                               0.490       0.185    **0.039**   0.170    0.059         0.149    0.098       0.058    0.520       −0.071   0.431
  Inner temporal                                     0.050                                                                               0.585       0.022    0.808       0.253    **0.005**     0.206    **0.022**   −0.034   0.708       −0.045   0.621
  Inner inferior                                     −0.001                                                                              0.993       0.124    0.169       0.318    **\<0.001**   0.189    **0.035**   −0.101   0.262       0.076    0.404
  Outer temporal                                     −0.007                                                                              0.937       0.165    0.067       0.066    0.466         0.225    **0.012**   −0.005   0.955       −0.030   0.737
  Outer inferior                                     −0.106                                                                              0.240       0.214    **0.017**   0.111    0.220         0.155    0.087       −0.028   0.755       0.010    0.910
  **Outer plexiform**                                                                                                                                                                                                                               
  Inner superior                                     −0.141                                                                              0.118       0.231    **0.010**   0.038    0.678         0.106    0.243       0.117    0.196       −0.170   0.059
  Outer superior                                     −0.047                                                                              0.603       0.291    **0.001**   0.013    0.883         0.042    0.640       0.122    0.178       −0.185   **0.040**
  Outer inferior                                     −0.025                                                                              0.782       0.196    **0.029**   −0.051   0.575         0.031    0.729       −0.006   0.946       −0.021   0.817
  **Outer nuclear**                                                                                                                                                                                                                                 
  Central fovea                                      0.006                                                                               0.943       0.048    0.597       0.078    0.390         −0.194   **0.031**   −0.057   0.529       0.016    0.863
  Inner nasal                                        0.023                                                                               0.801       −0.059   0.515       −0.002   0.986         −0.179   **0.047**   −0.035   0.697       −0.036   0.689
  Inner superior                                     0.168                                                                               0.063       −0.136   0.131       −0.058   0.522         −0.295   **0.001**   −0.018   0.845       −0.002   0.982
  Inner temporal                                     0.148                                                                               0.102       −0.003   0.972       −0.170   0.059         −0.121   0.182       0.150    0.096       −0.217   **0.016**
  Outer superior                                     0.141                                                                               0.118       −0.060   0.508       −0.053   0.561         −0.226   **0.012**   0.059    0.517       −0.059   0.515
  Outer temporal                                     0.111                                                                               0.222       −0.044   0.629       −0.118   0.193         −0.153   0.090       0.191    **0.034**   −0.207   **0.021**
  Outer inferior                                     0.107                                                                               0.236       −0.078   0.390       −0.115   0.203         −0.150   0.095       0.168    0.062       −0.201   **0.025**
  **IS/OS**                                                                                                                                                                                                                                         
  Central fovea                                      0.102                                                                               0.259       −0.035   0.699       −0.115   0.202         −0.033   0.719       0.189    **0.036**   −0.139   0.123
  Inner nasal                                        0.066                                                                               0.468       −0.045   0.621       −0.183   **0.042**     −0.067   0.457       0.142    0.115       −0.194   **0.031**
  Inner superior                                     0.056                                                                               0.535       −0.043   0.632       −0.167   0.064         −0.075   0.409       0.244    **0.006**   −0.191   **0.034**
  Inner temporal                                     0.067                                                                               0.463       −0.024   0.795       −0.215   **0.017**     −0.074   0.416       0.156    0.084       −0.159   0.078
  Inner inferior                                     0.025                                                                               0.779       −0.040   0.659       −0.235   **0.009**     0.010    0.914       0.191    **0.034**   −0.180   **0.046**
  Outer nasal                                        0.094                                                                               0.299       −0.015   0.865       −0.198   **0.028**     −0.287   **0.001**   0.042    0.646       −0.073   0.418
  Outer superior                                     0.196                                                                               **0.029**   −0.078   0.389       −0.272   **0.002**     −0.113   0.212       0.278    **0.002**   −0.186   **0.039**
  Outer temporal                                     0.249                                                                               **0.005**   −0.062   0.495       −0.222   **0.013**     −0.084   0.351       0.095    0.292       −0.047   0.608
  Outer inferior                                     0.200                                                                               **0.026**   −0.085   0.349       −0.308   **0.001**     −0.099   0.272       0.215    **0.016**   −0.132   0.143
  **Outer segment**                                                                                                                                                                                                                                 
  Inner inferior                                     0.024                                                                               0.793       0.038    0.674       −0.183   **0.042**     0.047    0.607       0.047    0.608       −0.055   0.541
  Outer nasal                                        −0.043                                                                              0.639       −0.019   0.836       −0.105   0.246         −0.185   **0.040**   −0.055   0.544       −0.005   0.957
  Outer temporal                                     0.178                                                                               **0.048**   −0.071   0.433       −0.295   **0.001**     −0.099   0.272       0.067    0.463       −0.052   0.570
  Outer inferior                                     0.089                                                                               0.324       0.006    0.951       −0.195   **0.030**     −0.086   0.344       0.100    0.268       −0.031   0.729
  **OPR**                                                                                                                                                                                                                                           
  Inner temporal                                     0.025                                                                               0.780       −0.055   0.544       −0.200   **0.026**     −0.140   0.121       0.063    0.485       −0.137   0.130
  Outer nasal                                        0.007                                                                               0.938       0.022    0.806       −0.107   0.236         −0.251   **0.005**   0.005    0.960       −0.117   0.195
  **RPE**                                                                                                                                                                                                                                           
  Central fovea                                      0.192                                                                               **0.032**   −0.069   0.449       0.032    0.724         0.004    0.969       0.018    0.840       −0.021   0.815
  Outer nasal                                        0.013                                                                               0.885       0.010    0.916       0.149    0.100         0.140    0.120       −0.075   0.405       0.218    **0.015**
  Outer superior                                     0.009                                                                               0.918       −0.016   0.862       0.206    **0.022**     0.065    0.474       −0.156   0.083       0.255    **0.004**
  Outer temporal                                     −0.050                                                                              0.578       −0.071   0.430       0.214    **0.017**     0.029    0.750       −0.146   0.105       0.280    **0.002**
  Outer inferior                                     −0.024                                                                              0.789       0.020    0.830       0.187    **0.037**     0.150    0.096       −0.097   0.284       0.214    **0.017**

*Bold p-value reveals p \< 0.05*.

*BMI, body mass index; HDL, high density lipoprotein; IS/OS, junction of inner and outer segment of photoreceptor; LDL, low density lipoprotein; OPR, outer segment of photoreceptor/retinal pigment epithelium complex; RNF, retinal nerve fiber; RPE, retinal pigment epithelium + Bruch\'s membrane complex*.

The television watching time on workday was positively associated with the global score and three individual sleep disorder scores and negatively associated with the thickness at a grid of three macular neuroretinal layers. That on free day was negatively related to the thickness at two OPL grids. The time of personal computer operation on workday was negatively linked to the thickness at a GCL and four OPL grids. That on free day was positively associated with the global score and four individual scores of sleep disorder and negatively associated with the thickness at a GCL and OPL grid. The mobile phone use on workday was negatively associated with the thickness at an IS/OS grid. The sunlight exposure on workday was negatively related to the thickness at a GCL grid and six RPE grids, and that on free day was negatively associated with the daytime dysfunction score ([Table 6](#T6){ref-type="table"}).

###### 

Linear regression between temporal structures of daily life and components of Pittsburgh Sleep Quality Index Japanese Version or the thickness at grids defined by Early Treatment Diabetic Retinopathy Study of macular neuroretinal layers and RPE in patients with type 2 diabetes without diabetic neuropathy.

                                                 **Temporal structures of daily life**                                                                                                                                                  
  ---------------------------------------------- --------------------------------------- ----------- -------- ----------- -------- ----------- -------- ----------- -------- ----------- -------- ------- -------- ----------- -------- -----------
  **PSQI-J Score**                                                                                                                                                                                                                      
  Global                                         0.191                                   **0.033**   0.038    0.677       −0.083   0.358       0.267    **0.003**   0.004    0.965       −0.018   0.845   0.022    0.804       −0.038   0.675
  Sleep quality                                  0.038                                   0.677       −0.037   0.687       0.100    0.267       0.299    **0.001**   0.077    0.395       0.043    0.637   0.023    0.801       −0.039   0.669
  Sleep-onset latency                            0.215                                   **0.017**   0.065    0.471       −0.122   0.178       0.155    0.086       −0.061   0.502       0.001    0.994   0.074    0.413       −0.082   0.368
  Sleep duration                                 0.227                                   **0.011**   0.109    0.228       0.020    0.822       0.123    0.173       0.059    0.515       −0.008   0.931   −0.027   0.768       0.078    0.388
  Sleep efficiency                               0.216                                   **0.016**   −0.048   0.596       0.001    0.987       0.181    **0.045**   0.064    0.478       0.101    0.264   0.057    0.530       0.176    0.051
  Sleep disturbance                              −0.064                                  0.478       0.016    0.862       0.053    0.560       0.279    **0.002**   −0.065   0.472       −0.054   0.548   0.149    0.099       0.085    0.346
  Sleep medication use                           0.022                                   0.806       −0.136   0.133       −0.067   0.462       0.241    **0.007**   −0.161   0.074       0.065    0.476   −0.038   0.676       0.057    0.528
  Daytime dysfunction                            0.097                                   0.283       −0.015   0.872       −0.035   0.700       0.048    0.599       −0.058   0.524       −0.105   0.248   0.046    0.612       −0.178   **0.048**
  **Thickness of macular neuroretina and RPE**                                                                                                                                                                                          
  RNFL Inner inferior                            −0.197                                  **0.028**   −0.039   0.664       0.142    0.114       −0.021   0.819       −0.062   0.491       −0.094   0.302   0.119    0.190       0.076    0.403
  GCL Inner temporal                             −0.119                                  0.189       −0.050   0.585       −0.027   0.767       0.040    0.662       0.005    0.959       0.053    0.562   −0.186   **0.039**   −0.115   0.204
    Outer nasal                                  0.149                                   0.099       0.161    0.075       −0.184   **0.041**   −0.190   **0.034**   −0.005   0.959       0.052    0.570   0.034    0.706       −0.059   0.515
  INL Inner temporal                             −0.194                                  **0.030**   −0.153   0.089       0.033    0.720       0.023    0.800       0.044    0.630       0.022    0.805   −0.061   0.501       −0.076   0.404
  OPL Central fovea                              0.038                                   0.674       −0.053   0.555       −0.181   **0.047**   −0.197   **0.028**   0.147    0.103       0.014    0.877   −0.144   0.110       −0.123   0.172
    Inner temporal                               −0.252                                  **0.005**   −0.243   **0.007**   −0.125   0.166       −0.055   0.542       0.015    0.866       −0.101   0.265   0.048    0.594       −0.161   0.073
    Inner inferior                               −0.004                                  0.964       −0.075   0.407       −0.211   **0.019**   −0.031   0.733       0.087    0.336       −0.108   0.232   −0.027   0.763       −0.066   0.466
    Outer temporal                               −0.100                                  0.267       −0.182   **0.043**   −0.183   **0.045**   −0.091   0.312       0.104    0.251       −0.061   0.500   0.080    0.377       −0.122   0.179
    Outer inferior                               0.032                                   0.726       −0.063   0.484       −0.242   **0.007**   −0.062   0.492       0.111    0.219       −0.105   0.248   −0.065   0.475       −0.153   0.091
  IS/OS Inner nasal                              −0.028                                  0.755       −0.065   0.473       −0.027   0.769       0.111    0.218       −0.190   **0.035**   −0.069   0.447   0.003    0.975       −0.088   0.330
  OS Outer superior                              −0.004                                  0.965       0.037    0.684       −0.126   0.165       0.071    0.432       −0.040   0.659       −0.032   0.723   −0.182   **0.043**   −0.075   0.406
  RPE Inner nasal                                0.050                                   0.579       0.069    0.449       −0.076   0.404       −0.063   0.487       −0.122   0.176       −0.096   0.290   −0.220   **0.014**   −0.113   0.213
    Inner superior                               0.022                                   0.804       0.083    0.361       −0.055   0.547       −0.051   0.575       −0.137   0.130       −0.097   0.282   −0.185   **0.039**   −0.124   0.171
    Outer nasal                                  0.009                                   0.918       0.132    0.144       0.089    0.327       0.051    0.572       −0.109   0.229       −0.022   0.810   −0.295   **0.001**   −0.055   0.547
    Outer superior                               0.019                                   0.832       0.106    0.243       −0.056   0.539       −0.035   0.703       −0.102   0.261       −0.028   0.757   −0.245   **0.006**   −0.067   0.461
    Outer inferior                               0.021                                   0.813       0.110    0.226       −0.053   0.558       −0.054   0.554       −0.035   0.702       0.007    0.942   −0.222   **0.013**   −0.059   0.516

*Bold p-value reveals p \< 0.05*.

*GCL, ganglion cell layer; INL, inner nuclear layer; IS/OS, junction of inner and outer segment of photoreceptor; OPL, outer plexiform layer; PC, personal computer; PSQI-J, Pittsburgh Sleep Quality Index Japanese Version; RNFL, retinal nerve fiber layer; RPE, retinal pigment epithelium + Bruch\'s membrane complex*.

The chronotype was positively associated with the global score (*r* = 0.202, *p* = 0.024), latency of sleep-onset score (*r* = 0.228, *p* = 0.011), and the thickness at two INL grids (*r* = 0.183, 0.210, *p* = 0.042, 0.019). The social jetlag was positively related to the daytime dysfunction score (*r* = 0.204, *p* = 0.023) and negatively related to the thickness at three ONL grids (*r* = −0.196 to −0.230, *p* = 0.029--0.010).

Discussion {#s4}
==========

Sleep disorder in people with diabetes has important clinical implications including impaired daytime functioning, poor glucose regulation, and poor quality of life ([@B21]). Hence, the assessment of the sleep disorder is essential for the effective management of diabetes ([@B22]). However, sleep disorder has not been investigated in detail in patients with diabetes.

The current paper assessed the detailed association between altered neuroretinal structures with the components of the sleep disorder in a cohort of patients with type 2 diabetes without clinical evidences of retinopathy and neuropathy. The sleep disorder was evaluated using the validated PSQI-J. The results revealed the higher prevalence, global score, and four individual scores of the sleep disorder in diabetic patients than controls. The OCT results confirmed the altered neuroretinal structures in diabetic patients compared to controls, and the thinning in outer retinal layers was more marked than that in inner retinal layers. In *db/db* mice, a murine model of spontaneous type 2 diabetes, and other diabetic animal models, the degeneration of neuroretina was found using OCT before the development of diabetic retinopathy ([@B23]). The mechanisms of neuroretinal degeneration by diabetes remain to be fully elucidated. However, oxidative stress, extracellular glutamate accumulation, and insufficient retinal production of neuroprotective factors such as pigment epithelial-derived factor and interstitial retinol-binding protein may play a role ([@B24]). Photoreceptors contain most of the mitochondria found in the retina and are the major site of superoxide generation in diabetes ([@B25]). These results are compatible with the more marked thinning of outer retina than that of inner retina.

Sleep is regulated by homeostatic and circadian mechanisms ([@B4]). In the homeostatic mechanism, prolonged wakefulness increases sleep drive, whereas the circadian oscillator partitions sleep within the day and night cycle. In the modern post-industrial society, people are always exposed to light except during sleep and continuous light exposure disturbs sleep, predominantly by modulating the circadian rhythm in a photoentrainment. In the eye, ipRGCs are responsible for conveying retinal light stimuli to suprachiasmatic nucleus ([@B6]) and hence setting the photoentrainment of circadian rhythm, and finally, control the melatonin secretion from pineal gland for regulating sleep ([@B26]). Because the signal from the ipRGCs is modulated by inputs from the photoreceptors via the synapses with bipolar and amacrine cells ([@B27]), the function and morphology of ipRGCs, cone-rod, and synapses between them should be evaluated separately for exploring the causes of the sleep disorder evoked by compromised photoentrainment. Because the ipRGCs occupy only 0.2% of total ganglion cell population at the retina ([@B5]), OCT cannot identify ipRGCs. The studies in blind people due to photoreceptor dysfunction ([@B28]) and pupillary light reflex using chromatic light ([@B6]) evidenced the pivotal role of a small number of ipRGCs in non-visual light sensing and sleep regulation. However, we did not have direct evidence suggesting the causal role of impaired ipRGC function in sleep disorder of diabetic patients. As IPL is composed of the network between ipRGCs and amacrine or bipolar cells, the thinning of IPL potentially contributes to the impairment of ipRGC function. The thickness at five IPL grids in diabetic patients was thinner than controls, suggesting that the thinning of the IPL plays a possible role in high scores of sleep efficiency, sleep disturbance, and the use of sleep medications due to potentially compromised photoentrainment by disrupting the network between ipRGCs and photoreceptors.

The thickness of four ONL grids in patients with diabetes was thinner than control subjects and was inversely related to the global score and scores of sleep efficiency, sleep medication use, and daytime dysfunction. ONL defined by OCT-Explorer ([@B20]) contains nuclei and IS of photoreceptor where mitochondria are abundant. Seventy percent of retinal mitochondria locate in photoreceptors, and in diabetes, photoreceptor cells are a major contributor to diabetes-induced oxidative stress and local inflammation in the retina ([@B25]). Therefore, the impaired photoreceptor function by the thinning of ONL potentially compromised photoentrainment, resulting in sleep disorder.

OPR plays an important role for the clearance of shed outer segment discs and the maintenance of pH, ion concentration, and fluid balance in subretinal space. The thickness of six OPR grids in diabetic patients was thinner than that in control subjects. It is plausible that the thinning of OPR had robust inverse relationship to the scores of sleep quality (integrated aspects of sleep process), sleep efficiency, and sleep disturbance of sleep disorder.

Recently, Dumpala et al. ([@B12]) reported the outer retinal thinning and dysfunction in a small number of patients with type 2 diabetes and inferred that outer retinal structure and function deficits contribute to the sleep disruption in type 2 diabetes. However, they determined the thickness of total outer retina and did not directly associate the individual components of sleep disorder with the thickness at ETDRS grids of each outer retinal layers.

The detailed association between sleep disorder and the thinning of the macular neuroretinal layers in patients with type 2 diabetes had never been investigated. In the present study, we determined the thickness at nine grids defined by ETDRS of nine macular neuroretinal layers and RPE. The thickness at one to seven grids of six macular neuroretinal layers and RPE in patients without diabetic neuropathy was significantly thinner than those in controls. However, the influence of diabetes on the thickness of the macular neuroretinal layers had not been consistent ([@B8], [@B29]), because OCT image quality depends on the instrument reliability and measurement variability ([@B30]). SS-OCT uses 1 μ wavelength light source, allowing deeper penetration into the photoreceptors and RPE ([@B31]). Because our SS-OCT cannot determine the individual thickness of the macular neuroretinal layers, we assessed it by processing SS-OCT images using OCT-Explorer ([@B20]), which enabled us to measure the thickness as thin as 10 μm. The CV of five measurements over 6 months in nine ETDRS grids of nine macular neuroretinal layers and RPE in 10 control subjects were \<5%, indicating good repeatability.

The sleep quality score was inversely related to the thickness of photoreceptors. HbA1c levels, LDL-cholesterol, and triglycerides negatively and HDL-cholesterol positively influenced the thickness of photoreceptors. Therefore, for improving sleep quality, hyperglycemia and dyslipidemia should be controlled. The previous cross-sectional studies revealed that sleep disorder contributed to hyperglycemia and dyslipidemia, while no prospective study indicating that the treatment of hyperglycemia or dyslipidemia improves sleep quality was found. Therefore, the benefit of treating hyperglycemia and dyslipidemia on sleep quality is tentative at the present time. The ONL thickness had a close negative relationship with the use of sleep medications and daytime dysfunction and had potentially negative association with LDL-cholesterol and triglycerides and positive association with HDL-cholesterol. Correcting dyslipidemia can reduce sleep medications and improve daytime dysfunction.

Aging had potentially negative association with the thickness of inner retinal layers and positive association with the thickness of outer retinal layers and RPE ([@B32], [@B33]). RPE enlarges by aging due to the multinucleation ([@B33]). In a healthy population ([@B34]), aging is associated with the photoreceptor thinning and the thickening of RPE. The much older mean age (70.6 years) of the above study population than ours (48.6 years) might produce the difference. In the present study, BMI had a potentially positive influence on the thickness of inner retinal layers and OPL, while in the previous studies ([@B34], [@B35]), BMI does not affect the thickness of the macular neuroretinal layers. We did not have plausible explanation for the difference. The positive relationship between the INL thickness and HbA1c levels might be due to the hyperglycemia-induced swelling of Müller cells ([@B36]). The HbA1c levels negatively affected the thickness of photoreceptors and positively affected that of the inner retinal layers and RPE. Because the photoreceptors are a dominant source of retinal oxidative stress caused by hyperglycemia ([@B25]), diabetes may degenerate the photoreceptors. In the diabetic and hypercholesterolemic pig model, the blood-retinal barrier is impaired, and plasma components leak into RPE ([@B37]), making RPE edematous. In hypercholesterolemic rabbits, ONL was degenerated ([@B38]). These histological changes in animal models were compatible with the current findings that serum LDL-cholesterol levels negatively influenced the ONL thickness, contributing to the use of sleep medication and daytime dysfunction. The serum LDL-cholesterol levels were positively associated with the global score and two individual PSQI-J scores. The high total and LDL-cholesterol levels ([@B39], [@B40]) were associated with sleep disorder. We could not exclude the causal role of sleep disorder in inducing hypercholesterolemia.

The inappropriate light exposure may be associated with sleep disorder and reduced thickness of the macular neuroretinal layers. We estimated the duration of television watching, PC operation, mobile phone use, and sunlight exposure but did not measure the intensity of light during these periods. Therefore, we could not determine the quantitative association between amount of these light exposures and the scores of components of sleep disorder. The patients with type 2 diabetes watched TV much longer than control subjects. Their longer sedentary lifestyle such as watching TV may contribute to the development of type 2 diabetes. However, we do not know why they watched TV longer.

The chronotype and social jetlag were linked to the increase in the sleep disorder scores. The former was positively related to the INL thickness and the latter was negatively related to the ONL thickness. However, underlying mechanisms of their influence on the macular neuroretinal layer thickness were unknown.

In patients with type 2 diabetes, sleep disorder, especially obstructive sleeping apnea, is associated with diabetic peripheral neuropathy ([@B11]) and autonomic neuropathy ([@B41]). The altered median nerve amplitude, CVR-R, and beading structures of corneal nerve fibers were associated with the increased PSQI-J scores. Although we excluded the patients with confirmed diabetic peripheral neuropathy and sleep apnea, the questionable diabetic autonomic or sensory dysfunction can be a cause of sleep disorder in diabetic patients irrespective of retinal lesions. We briefly examined the influence of diabetic nephropathy on neuroretinal layer thickness and sleep disorder in the present diabetic cohort. ACR was negatively associated with the thickness at a grid of GCL, and eGFR was positively associated with the thickness at one to four grids of IPL, INL, OPL, and OPR. On the other hand, no significant association was found between scores of sleep disorder and ACR or eGFR. These results indicated that the severity of mild diabetic nephropathy did not influence sleep disorder. The association between diabetic nephropathy and neuroretinal layer thickness has to be confirmed by future studies.

In patients with type 2 diabetes, statin use improved 2 PSQI-J scores without changes in the macular neuroretinal layer thickness. The influence of statin on the sleep disorder had been inconclusive ([@B42]). Because the current study was cross-sectional and included the small number of patients using statin, prospective studies using a large number of patients with statin are needed to confirm the benefit of statin on sleep disorder.

Strengths and Limitations
-------------------------

The association between sleep disorder and clinical factors, macular neuroretinal layer thickness, or temporal structures of daily life in type 2 diabetes had not been fully investigated. The novelty of the current paper is that the thinning of IPL, ONL, and photoreceptors was closely associated with sleep disorder, and the temporal structures of daily life (exposure to various light sources) influenced the thickness of the macular neuroretinal layers. As we excluded patients with clinical evidences of diabetic retinopathy and neuropathy, the influence of these complications on sleep disorder and the macular neuroretinal layer thickness seems to be minimal. Because we examined the thickness of macular neuroretinal layers in detail, the association between the individual components of sleep disorder and the thickness of specific grids of macular neuroretinal layers was obtained. Our study had some limitations. Because the sample size was relatively small and diabetic controls with diabetic neuropathy or/and diabetic retinopathy were lacking, we could not clarify the impact of these complications on sleep disorder and its association with the thickness of the macular neuroretinal layers. Because our study did not include so many morbidly obese patients (BMI \> 30%: 26.6%), and excluded patients older than 55 years, we could not detect the influence of obesity and aging on sleep disorder. Therefore, we could not generalize the present results to European or American populations that include many super-obese type 2 diabetic patients. As we did not measure the arterial O~2~ concentration during sleep, the influence of hypoxia on the altered macular neuroretinal layer thickness could not be clarified. Although we found the association between the sleep disorder and the macular neuroretinal layer thinning, the causative role of the altered macular neuroretinal layers in sleep disorder remains to be clarified. Future studies are required to investigate this. The intensity of various light exposures was not evaluated, and we cannot determine the quantitative association between the amount of various light exposures and the components of sleep disorder. Finally, we did not evaluate the functions of neuroretinal layers. Although it is well-known that the ipRGCs play a key role in non-visual light sensing and regulation of circadian rhythm and sleep cycle, and signals from photoreceptors (ONL, OS) modulate the function of ipRGCs via synapse between them (IPL) ([@B27]), we cannot elucidate the influences of neuroretinal thinning on their functions relevant to impaired circadian mechanism. For elucidating the robust association between components of sleep disorder and neuroretinal alterations, the simultaneous evaluations of function and structure of neuroretinal layers are mandatory.

In conclusion, the thinning of IPL, ONL, and photoreceptors caused by hyperglycemia and dyslipidemia in type 2 diabetes without diabetic retinopathy and neuropathy was related to sleep disorder. To improve sleep disorder, controlling hyperglycemia and dyslipidemia is essential. However, interpreting the causal role of structural alterations in IPL, ONL, and photoreceptors in the sleep disorder requires a prospective study. Modifying temporal structures of daily life, especially television watching for a long time, may improve sleep disorder, and consequently, in the long term, this will improve the management of diabetes.
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ETDRS

:   Early Treatment Diabetic Retinopathy Study

GCL

:   ganglion cell layer

INL

:   inner nuclear layer

IPL

:   inner plexiform layer

IS/OS

:   junction of inner and outer segment of photoreceptor

OCT

:   optical coherence tomography

ONL

:   outer nuclear layer

OPL

:   outer plexiform layer

OPR

:   outer segment of photoreceptor/retinal pigment epithelium complex

PSQI-J

:   Pittsburgh Sleep Quality Index Japanese Version

RNFL

:   retinal nerve fiber layer

RPE

:   retinal pigment epithelium + Bruch\'s membrane complex.
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